Valsartan Lawsuit Lawyers How to Receive FULL Monetary Compensation When Recalled Valsartan Caused Your Cancer Claims & Settlement Information for Organ Cancer Caused By Generic Valsartan, Irbesartan, Losartan Contamination Numerous lawsuits have been filed against drug manufacturers, marketers and sellers over prescribed generic heart medications found to be tainted with known carcinogens, the first claims […]
Numerous lawsuits have been filed against drug manufacturers, marketers and sellers over prescribed generic heart medications found to be tainted with known carcinogens, the first claims of which our firm’s attorneys expect to be a wave of litigation.
Valsartan lawsuits are being filed against the manufacturers and sellers of generic forms of Valsartan, Irbesartan, Losartan medications which were recalled in 2018. These lawsuits and the future lawsuits our firm will file seek to recover monetary compensation for high blood pressure patients who took certain generic drugs that were contaminated with cancer-causing chemicals and later were diagnosed with liver cancer, stomach cancer, intestinal cancer, and/or colorectal cancer.
When a patient is prescribed a medication to treat a medical condition or alleviate symptoms, some side effects are expected. However, no one expects that the medications they are taking are unsafe or even deadly because of negligent manufacturing processes. We expect that drug manufacturers will follow all of the safety requirements, standards and guidelines set forth by the FDA here in the United States even while making the medications in a foreign country. Especially when marketing these drugs here in the United States.
In this case, numerous Valsartan lawsuits allege the manufacturer used cancer causing chemicals in the manufacturing process and the sellers and distributors of these medications neglected to ensure these drugs were safe and contamination-free. Our law firm is appalled by these actions that put you or those you love at a high risk of developing several types of organ cancer.
Parker Waichman LLP is offering a free claim review to help patients who took Valsartan, Irbesartan, Losartan and have developed cancer. Simply call Parker Waichman LLP right now at 1-800-YOURLAWYER (1-800-968-7529) for your free Valsartan cancer claim review.
In 2018, the U.S. Food and Drug Administration recalled Valsartan and other related drugs because of N-nitrosodimethylaminecontamination. According to the EPA, N-nitrosodimethylamineis a known carcinogen. Patients who were prescribed generic Valsartan from 2012 to 2018 were unknowingly consuming N-nitrosodimethylaminedaily and for many years.
In 2018,Valsartan, a medication used to treat congestive heart failure and hypertension (high blood pressure), was recalled by the U.S. Food and Drug Administration due to N-nitrosodimethylamine (NDMA) contamination. The FDA also issued 45 blood pressure medication recalls for generic drugs such as Losartan and Irbesartan and brand name drugs such as Valsartan, Amlodipine, and Losartan. According to the EPA, N-nitrosodimethylamine(NDMA) is a known carcinogen. A total of twenty-two countries have issues safety recalls of Valsartan, Amlodipine, and Losartan. The FDA asserted that these medications contaminated with N-nitrosodimethylamineput those prescribed the drugs at a high risk of developing cancer. Numerous lawsuits maintain that theseN-nitrosodimethylamine contaminated drugs caused liver cancer, intestinal cancer, stomach cancer and colorectal cancer.
On May 6, 2019, the FDA sent out another losartan-containing medication alert to health care professionals and patients warning of a recall of 19 lots of losartan potassium tablets which are sold by Heritage Pharmaceuticals Inc, East Brunswick, New Jersey and are manufactured by Vivimed Life Sciences Pvt Ltd based in Alathur, Chennai, India. The recall was initiated because some lots tested positive of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA). Vivimed has recalled several lots of its generic, losartan-containing medication which had tested positive for NMBA at 9.82 parts per million or more. This meets the interim acceptable intake limit of allowable NMBA set by the FDA during their investigation. The maximum allowable NMBA set by the FDA is 0.96 parts per million. The FDA will review each drug on a case-by-case basis to determine whether the amount of NMBA may exceed 0.96 parts per million. The FDA recommends that all patients who are taking a recalled angiotensin II receptor blockers or ARBs to continue to take their medication, as prescribed, until their doctor or pharmacist provides an alternative medication.
The FDA’s website provides a detailed list of its recalled Angiotensin II Receptor Blockers (ARBs)including Valsartan, Losartan and Irbesartan.
Lawsuits filed against the manufactures and sellers of generic Valsartan allege the N-nitrosodimethylaminecontamination caused individuals to develop liver damage, liver cancer, stomach cancer, Intestinal cancer, and colorectal cancer as a result.
According to an FDA Recall Update, a second impurity, N-Nitrosodiethylamine (NDEA), which is also a known carcinogen, was discovered reacquiring Torrent Pharmaceuticals’ to recall its valsartan drug productson August 23, 2018.
According to the FDA, recent FDA testing has concluded that “not all valsartan products contain NDMA or NDEA,” which is good news for many patients. Also, pharmacies may have alternative options for filling valsartan prescription and physicians may prescribe safe alternative medications that treat high blood pressure.
Call Parker Waichman LLP right now at 1-800-YOURLAWYER (1-800-968-7529)you’re your free Valsartan lawsuit review with one of our caring and knowledgeable Valsartan lawyers and see if you have a case.
Valsartan lawsuit pleadings allege the active ingredients, for Valsartan and related drugs, were manufactured inside unsafe, unregulated manufacturing plants located in China and India. A report by GMP-Compliance.org states the N-nitrosodimethylamine contamination was the result of a change in the manufacturing process. In this report, “N,N- dimethylformamide (DMF) had been used as a new solvent” in the manufacturing process since 2012.
A former FDA inspector substantiated those allegations in an interview when he stated that those manufacturing plants were not properly managed. The lack of quality management resulted in systemic failures leading to the use of a N-nitrosodimethylaminesolvent, a known carcinogen, in the medications’ manufacturing process. The former FDA inspector also stated that he tried to have regulators issue an immediate FDA recall but was unsuccessful.
German pharmaceutical researcher and professor Dr. Fritz Sörgel stated in a German Apotheke Adhoc article, that the discovery N,N- dimethylformamide being used in the manufacturing process “seems like the contamination had been discovered by chance” and this astonished Professor Sörgel.
In an FDA press release, the FDA recommends that patients should contact their pharmacist and prescribing physician as soon as possible. The FDA also recommends that patients continue taking their current prescribed medications until a pharmacist or their prescribing physician provides a different treatment option.
If you or a loved one has been taking Valsartan, Amlodipine, Diovan, Losartan or any other Angiotensin II Receptor Blocker (ARB), speak with your prescribing physician and then make the call to Parker Waichman LLP to receive your free Valsartan cancer claim review. You or your loved one may be entitled to recover monetary compensation for medical expenses, emotional distress, loss of income, pain and suffering. In some cases, you may also be able to recover punitive damages. Punitive damages, if awarded by a judge or jury, are meant to punish the drug company for their negligent or illegal actions. The time you have to collect monetary compensation is limited by law.
To receive your free Valsartan claim review, call Parker Waichman LLP today at 1-800-YOURLAWYER (1-800-968-7529).
Parker Waichman LLP has recovered over $2 billion in settlements, jury verdicts and awards. At Parker Waichman LLP, our Valsartan lawsuit attorneys put forth the maximum skill, hard work and determination necessary to recover the maximum amount of compensation our client deserves. Legal professionals understand the suffering you or your loved one has endured and we strive to results your case deserves.
Parker Waichman LLP has been empowering victims of defective drugs and dangerous products decades. Our national products liability law firm has garnered numerous awards and recognition for results.
Parker Waichman LLP is the law firm with the reputation, experience and results that you can count on for your case. If you or a member of your family has developed liver damage or cancer of the liver, intestines, colon, or stomach, contact our law office today to learn if your situation is eligible to file a Valsartanlawsuit against the sellers and manufacturers of generic Valsartan or to negotiate your Valsartan settlement. Simply call 1-800-YOURLAWYER (1-800-968-7529) for your free Valsartan cancer case review with an experienced Valsartan attorney.
If you or a loved one have been prescribed Valsartan, Generic Valsartan, Irbesartan, Losartan, Amlodipine, or Diovan, call Parker Waichman LLP today at 1-800-YOURLAWYER (1-800-968-7529) for your free Valsartan claim review. You may also contact Parker Waichman LLP by using our Website Contact Form or Live Chat feature.